Connection

Bryan Toole to Cell Proliferation

This is a "connection" page, showing publications Bryan Toole has written about Cell Proliferation.
Connection Strength

0.254
  1. CD147-dependent heterogeneity in malignant and chemoresistant properties of cancer cells. Am J Pathol. 2013 Feb; 182(2):577-85.
    View in: PubMed
    Score: 0.077
  2. Hyaluronan oligosaccharides as a potential anticancer therapeutic. Curr Pharm Biotechnol. 2008 Aug; 9(4):249-52.
    View in: PubMed
    Score: 0.057
  3. Role of heme oxygenase-1 in the pathogenesis and tumorigenicity of Kaposi's sarcoma-associated herpesvirus. Oncotarget. 2016 Mar 01; 7(9):10459-71.
    View in: PubMed
    Score: 0.024
  4. CD147 and downstream ADAMTSs promote the tumorigenicity of Kaposi's sarcoma-associated herpesvirus infected endothelial cells. Oncotarget. 2016 Jan 26; 7(4):3806-18.
    View in: PubMed
    Score: 0.024
  5. Cancer may be a pathway to cell survival under persistent hypoxia and elevated ROS: a model for solid-cancer initiation and early development. Int J Cancer. 2015 May 01; 136(9):2001-11.
    View in: PubMed
    Score: 0.021
  6. Mesenchymal CD44 expression contributes to the acquisition of an activated fibroblast phenotype via TWIST activation in the tumor microenvironment. Cancer Res. 2013 Sep 01; 73(17):5347-59.
    View in: PubMed
    Score: 0.020
  7. Direct activation of emmprin and associated pathogenesis by an oncogenic herpesvirus. Cancer Res. 2010 May 15; 70(10):3884-9.
    View in: PubMed
    Score: 0.016
  8. Conditional inactivation of Has2 reveals a crucial role for hyaluronan in skeletal growth, patterning, chondrocyte maturation and joint formation in the developing limb. Development. 2009 Aug; 136(16):2825-35.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.